Form 4 for GMED GLOBUS MEDICAL INC
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001209191-23-008737 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-13 | 2023-02-09 | GMED | Lemaitre Dan | Dir | M - OptEx | $23.95 | +5,550 | 10.8K | +106% | +$132.9K |
| D | 2023-02-13 | 2023-02-09 | GMED | Lemaitre Dan | Dir | M - OptEx | $0.00 | -5,550 | 1,450 | -79% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-02-09 | M | A | 5,550 | $23.95 | 10,800 | D | — | — | |
| 2 | Derivative | Stock Option (Right to Buy Class A Common Stock) | 2023-02-09 | M | D | 5,550 | $0.00 | 1,450 | D | $23.95 · — to 2024-01-23 | 5,550 Class A Common Stock | (F1) These options were granted on January 23, 2014 and are fully vested. |